Literature DB >> 3492428

Recombinant human granulocyte colony stimulating factor: molecular and biological characterization.

K M Zsebo, A M Cohen, D C Murdock, T C Boone, H Inoue, V R Chazin, D Hines, L M Souza.   

Abstract

Human or rodent bone marrow treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a CFU-GM assay yield predominantly granulocytic colonies. The specificity for granulocyte progenitors in vitro is also demonstrated in vivo by a five- to six-fold elevation in hamster peripheral blood neutrophils. Other cell types (monocytes, lymphocytes and eosinophils) remain stable. Analysis of mRNA from the bladder carcinoma cell line 5637 (1A6) shows the predominant species of mRNA codes for a mature protein of 174 amino acids. A small fraction of the mRNA can code for an alternative form of hG-CSF containing additional three amino acids between positions 35 and 36.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492428     DOI: 10.1016/S0171-2985(86)80097-3

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  19 in total

1.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

2.  Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride.

Authors:  L O Narhi; W C Kenney; T Arakawa
Journal:  J Protein Chem       Date:  1991-08

Review 3.  Human granulocyte colony stimulating factor.

Authors:  E Platzer; J R Kalden
Journal:  Blut       Date:  1987-03

4.  In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; K M Zsebo; H Inoue; D Hines; T C Boone; V R Chazin; L Tsai; T Ritch; L M Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 5.  Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer.

Authors:  Elizabeth Comen; Patrick G Morris; Larry Norton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-09-26       Impact factor: 2.673

6.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

7.  Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

Authors:  C G Kolvenbach; S Elliott; R Sachdev; T Arakawa; L O Narhi
Journal:  J Protein Chem       Date:  1993-04

8.  Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahemd E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

Review 9.  Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Authors:  Athanasia D Panopoulos; Stephanie S Watowich
Journal:  Cytokine       Date:  2008-04-08       Impact factor: 3.861

10.  Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome.

Authors:  P Artur Plett; Carol H Sampson; Hui Lin Chua; Mandar Joshi; Catherine Booth; Alec Gough; Cynthia S Johnson; Barry P Katz; Ann M Farese; Jeffrey Parker; Thomas J MacVittie; Christie M Orschell
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.